The reference (b)(6) has been allocated to this case by rayner.The patient underwent iol implantation on (b)(6) 2022 and one day post-operatively presented with toxic anterior segment syndrome (tass).Disposable surgical instruments were used and surgery was performed without complication.The patient has been prescribed yellox x2 daily, vancomycin fortum infusions, has undergone pars plana vitrectomy and vitroeus tap (no germ detectable).The healthcre facility has confirmed that the patient's symptoms have resolved following treatment.The aetiology of tass may be multi-factorial with numerous potential causes including but not limited to; bacterial endotoxins or particulate contamination of balanced salt solutions, intraocular irrigating solutions with abnormal ph, osmolarity or ionic composition, denatured ophthalmic viscosurgical devices (ovd), intraocular medications (antibiotics in the irrigation solutions or intracameral antibiotics), topical ointments, inadequate sterilization of surgical instruments and tubing, inadequate flushing of instruments between cases resulting in build-up of ophthalmic viscosurgical devices (ovd), preservative and metallic precipitate.Every batch of iols manufactured by rayner are tested for endotoxin and bioburden.Rayner's endotoxin acceptable tolerances are derived from bs en iso 11979-08 (2017) ophthalmic implants - intraocular lenses part 8 fundamental requirements.We have set our own limits for bioburden as there is no standard that prescribes acceptable limits.Our review of endotoxin and bioburden records for the batch confirms that the product tested within acceptable tolerance of the respective limits.No rayner microbiological cause for the onset of post-operative tass was identified.The root cause of the event has not been established.
|